ADHD and addictions — alcohol, cannabis, gambling, screens

Why this topic is central

If you’re an adult with ADHD, you have about 2 to 3 times more probability of developing a substance use disorder during your lifetime than a person without ADHD. The van Emmerik-van Oortmerssen (2012) meta-analysis compiled 29 studies and concluded that 23% of patients followed in addiction services have ADHD, vs 2 to 5% in the general population ^[1] . The Groenman (2017) meta-analysis confirms that childhood ADHD is an independent and early risk factor for addiction disorders in adolescence and adulthood ^[6] .

The most affected substances: alcohol, cannabis, cocaine, nicotine. Behavioural addictions (gambling, video games, screens, sex) are also overrepresented, although the literature is less solid for the latter ^[2] .

I smoked weed every day for 12 years. I told myself it was because it calms me, because I can’t stand my thoughts. It was true, actually. I realised when I stopped, diagnosed ADHD at 31, that what I was looking for in cannabis, the treatment gives me cleanly. Ritalin doesn’t get you high. It just makes the racket quiet.

Why the ADHD brain is vulnerable

The neurobiological explanation converges on dopamine ^[4] :

• Hypofunction of reward circuits: the ADHD brain struggles to anticipate future reward. Substances that give immediate reward (alcohol, nicotine, cannabis, cocaine, methamphetamines) temporarily relieve this hypofunction.
• Impulsivity: executive function deficit, difficulty inhibiting an urge, bias toward the short term. Consumption decisions taken “before thinking”.
• Internal chaos: the ADHD mental noise is exhausting. Alcohol, cannabis, benzodiazepines partially silence it. It’s self-medication, not pleasure.
• Accumulated social problems: school failures, breakups, isolation. Consumption environments (parties, groups) offer social acceptance that is otherwise rare.

It isn’t “weakness” or “misplaced pleasure”. It’s a brain that, without treatment, desperately seeks a way to function. The problem: short-term relief is real, long-term cost is major (dependence, cognitive damage, career, relationships).

Panorama of substances and behaviours

Alcohol

The most consumed substance, and one of the riskiest. Alcohol temporarily disinhibits, calms anxiety and mental noise, helps falling asleep (short term). But it worsens sleep quality, memory, mood, and emotional regulation. ADHD adults have a significantly increased risk of alcohol use disorder ^[1] .

Cannabis

The second most consumed substance by ADHD adults, often as self-medication for sleep and anxiety. Daily long-term cannabis actually worsens ADHD symptoms: it reduces motivation, impairs working memory, and in some adolescents and young adults accelerates psychotic disorders (dose-dependent risk). Stopping is hard: withdrawal generates anxiety, insomnia, irritability — the very symptoms you were trying to calm.

Nicotine

Smoking rates in ADHD adults are about 2 times higher than the general population. Nicotine has a short-term pro-cognitive effect in ADHD (it increases prefrontal dopamine) — which explains both the substance’s appeal and the difficulty quitting ^[2] .

Cocaine, illicit amphetamines

Also overrepresented. Beware the “it’s like my treatment so it’s fine” reasoning: illicit formulations are cut in purity, taken in peaks (not extended release), and associated with strong craving. The pharmacokinetic difference between cocaine and methylphenidate is fundamental — not the same risk profile.

Gambling, sports betting

Under-recognised comorbidity. The ADHD brain is particularly vulnerable to variable reward mechanisms (slot machines, online betting). Risk increased by about 2 to 3 times ^[2] .

Screens, video games, social media

Less mature literature, but strong signal: ADHD adults have more probability of problematic screen use. Variable reward mechanisms (notifications, infinite scroll, progression systems) directly exploit dopaminergic hypofunction. It isn’t strictly speaking a clinically recognised “addiction”, but functional impact can be major.

Crossed diagnosis — the separate-pathway trap

In France and elsewhere, addiction and ADHD services are often separated. Result: many patients in addiction services are never screened for ADHD, and conversely, many ADHD consultations ask few precise questions about consumption ^{[3] [5]} .

HAS recommends in 2024 systematic crossed screening when either diagnosis is raised ^[3] . The European consensus points the same way ^[5] .

Stimulants and addiction — myth vs reality

The persistent myth: “prescribing stimulants to an ADHD adult with an addiction history is giving them drugs”.

Documented reality ^{[2] [5]} :

• ADHD pharmacological treatment in patients with a substance use disorder history doesn’t increase addiction risk, and probably reduces it.
• Extended-release (ER) stimulants have a much lower abuse potential than immediate-release (IR) forms — prefer ER in these patients.
• Atomoxetine (non-stimulant) can be proposed if the risk of diversion is high.
• Prior abstinence is not an absolute prerequisite for starting ADHD treatment, per the European consensus. Some patients can only stop their substance after starting treatment.

Clinical evolution under ADHD treatment

In people with active substance use disorder + ADHD:

• ADHD treatment improves therapeutic engagement in addiction care.
• It significantly reduces relapses in the majority of studies.
• It improves the ability to keep appointments, do therapy homework, not lose sight of the care plan.
• The effect on craving itself is variable and less robust — ADHD treatment is not a craving treatment.

The most solid treatment scheme: ADHD treatment + specialised addiction care + CBT / motivational interviewing + sometimes substitution treatment depending on the substance.

Common myths to dismantle

“If you consume, it’s because you don’t want to stop.” No. It’s that your brain is giving you an immediate short-term relief signal, and that signal is hard to ignore without a credible alternative.

“You must stop first, then we treat the ADHD.” Clinical position that long dominated, today largely questioned. For many patients, stopping is only possible after starting to treat the ADHD ^[5] .

“Stimulants will make you addicted.” False in the vast majority of cases when prescribed at therapeutic dose, in ER, with follow-up. The risk exists mainly with IR forms used in diverted ways ^[2] .

“Alcohol relaxes you and treats your anxiety.” Short term yes. Long term, it worsens anxiety, destabilises sleep, and impairs already-fragile ADHD cognitive functions.

“Cannabis improves sleep.” Very widespread myth. Cannabis reduces sleep-onset latency but alters sleep architecture (reduced REM sleep), and generates withdrawal-related insomnia on stopping. Net long-term effect: negative.

What works clinically

1. Systematic crossed screening: ADHD in any addiction assessment, consumption in any ADHD consultation.
2. ADHD pharmacological treatment (preferably ER) without waiting for total abstinence.
3. Specialised addiction care: outpatient addiction services, hospital-based addiction medicine.
4. Motivational interviewing: validated approach to support change without confrontation.
5. Targeted CBT: relapse prevention, craving management, cognitive restructuring.
6. Peer support groups: AA, NA, ADHD-adapted groups if available.
7. Lifestyle: sleep, exercise, nutrition. Especially important to reduce the load that drives consumption.
8. Substitution treatment if indicated (methadone, buprenorphine, varenicline, naltrexone depending on the substance).

Contradictory evidence

• Not all work shows a marked protective effect of ADHD treatment on addictions. Some studies observe a neutral effect, especially in populations with severe multi-substance addictions.
• The question of benzodiazepines and GHB remains debated: these substances are used in self-medication by some ADHD adults but their dependence profile is concerning, and they strongly impair cognitive functions. Clinical consensus: avoid long-term ^[5] .
• The “ADHD treatment first” sequence isn’t appropriate for all profiles — in particular those with substance-induced psychosis or active IV use. Individualised clinical judgement required.

What we don’t know yet

• Why some ADHD adults develop addictions and others don’t.
• Efficacy profile of ADHD treatments on behavioural addictions (screens, gambling) remains under-studied.
• Long-term interactions of stimulants + opioid substitutes.
• The effect of microdosing (emerging practice, poorly documented) in this population.

To remember

• Addiction risk about 2 to 3 times higher in ADHD adults; 23% ADHD in followed addiction populations (vs 2–5% general population).
• Central mechanism: dopaminergic hypofunction + self-medication of mental noise.
• Treating ADHD does not increase addiction risk, and reduces it in the majority of cases.
• Systematic crossed screening recommended (HAS 2024, European consensus 2019).
• Treat both in parallel, not in rigid “abstinence first” sequence.

Going deeper

• Anxiety and adult ADHD
• Depression and adult ADHD
• Emotional dysregulation in adult ADHD
• ADHD — what it actually is